Calculation and analysis of the efficiency of resource allocation for technological innovation in China.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 19 02 2024
accepted: 04 08 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: epublish

Résumé

The efficiency of resource allocation in technological innovation is a critical factor influencing the output level of technological innovation. By expanding and optimizing the Hsieh & Klenow (2009) framework for analyzing the efficiency of resource allocation and relaxing the assumption of constant returns to scale, this study utilizes sample data from Chinese listed companies from 2007 to 2019 to measure and analyze the resource allocation efficiency level in China's technological innovation. The findings indicate that in the process of technological innovation, companies face heterogeneous resource usage costs, leading to a deviation from the optimal resource allocation state, with evident issues of resource misallocation. The loss of efficiency in technological innovation output due to resource misallocation is significant, and addressing this issue can substantially enhance the level of technological innovation output. The misallocation of research and development capital resources is more severe than that of research and development personnel, resulting in greater efficiency losses in technological innovation output. Government subsidies are identified as a significant factor affecting resource allocation in technological innovation. Addressing the issue of resource misallocation, accelerating the market-oriented reforms of technological innovation resource allocation, and optimizing the government subsidy screening mechanism are crucial for improving the efficiency of resource allocation in technological innovation.

Identifiants

pubmed: 39178298
doi: 10.1371/journal.pone.0308960
pii: PONE-D-24-06687
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0308960

Informations de copyright

Copyright: © 2024 Chen, Wu. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Ruying Chen (R)

School of Business, Linyi University, Linyi, Shandong, China.

Lanyu Wu (L)

School of Business, Linyi University, Linyi, Shandong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH